Category Archives: Coronary Heart Diseases

The longevity files: A strong grip? Push-ups? While researchers continue searching for a pill to extend life, you'll have to try these verified methods: So you want to live to a healthy old age Continue reading →

So you want to live to a healthy old age. But how? Continue reading →

MedicalResearch.com Interview with:Zara Berg, Ph.DFort Peck Community CollegePoplar, Montana MedicalResearch.com: What is the background for this study? Response: This study is part of the cohort that consist of the Honolulu Heart Program (HHP) and what later became the Honolulu-Asia Aging study. HHP study cardiovascular research starting in the 1960s, which is equivalent to the Framingham Study. Continue reading →

GlobalInterventional Cardiology Devices Market: Overview Interventional cardiology deals with the treatment of the heart related diseases such as coronary artery disease, congenital heart defect and aneurysm through catheter based devices. Continue reading →

Coronary Artery disease (CAD) is a cardiovascular disorder which is caused by reduced flow or absent of blood flow in arteries that enclose and supply the heart which is commonly known as Ischemia. Continue reading →

Reprinted with permission from World At Large, a news website of nature, science, health, politics, and travel. For the last three decades, scientists in Eastern Finland have been researching the effects of sauna bathing on thousands of men and womenand have uncovered some amazing trends. Continue reading →

Women with high blood pressure in pregnancy, including conditions such as pre-eclampsia, have an increased risk of developing cardiovascular disorders later in life, including stroke and heart failure, new research has found. Dr Fergus McCarthy from the Infant Research Centre at University College Cork, while working at Kings College London, led a team of researchers that studied electronic UK health records from 1997 to 2016 to recreate a UK population-based cohort of 1.3 million women covering nearly 1.9 million completed pregnancies. A statistical analysis was used to determine the associations between hypertensive disorders of pregnancy, such as pre-eclampsia, and 12 cardiovascular disorders Continue reading →

The new biomarker, 'fingerprint' will help the healthcare industry to save more lives by detecting early signs of a heart attack. FREMONT, CA: Harnessing cutting-edge artificial intelligence technologies could bring new hope for people with heart diseases. Continue reading →

Women with high blood pressure in pregnancy at increased risk of developing cardiovascular disorders Independent.ie Women with high blood pressure in pregnancy - including conditions such as pre-eclampsia - have an increased risk of developing cardiovascular disorders later in life, including stroke and heart failure, new research has revealed. https://www.independent.ie/irish-news/health/women-with-high-blood-pressure-in-pregnancy-at-increased-risk-of-developing-cardiovascular-disorders-38527461.html https://www.independent.ie/incoming/article38527479.ece/a1968/AUTOCROP/h342/photos_173938382_xl-2015.jpg Women with high blood pressure in pregnancy - including conditions such as pre-eclampsia - have an increased risk of developing cardiovascular disorders later in life, including stroke and heart failure, new research has revealed. Dr Fergus McCarthy from the INFANT Research Centre at University College Cork, while working at Kings College London, led a team of researchers that studied electronic UK health records from 1997 to 2016 to recreate a UK population-based cohort of 1.3 million women covering nearly 1.9 million completed pregnancies Continue reading →

Resverlogix is a few days away from releasing topline results from their phase 3 clinical trial, BETonMACE, a trial that aims at showing that Apabetalone (RVX208), a BET bromodomain inhibitor, reduces the risk of heart attacks, stroke and cardiac death in a high-risk population of diabetes patients with low HDL and established cardiovascular disease. The last patient has received the last dose of Apabetalone (or placebo), the last patient has had the last follow-up and the database lock took place on September 19. Management has put out on or about September 30 as the date where topline results will be released Continue reading →